Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
In any scenario, personalized treatment strategies and meticulous monitoring are indispensable to ensure the best possible therapeutic outcomes
Eli Lilly (LLY +0.87%) and Novo Nordisk (NVO +1.30%) are the clear front-runners, but which one has the edge heading into next year
W., Greig N
Erythropoietic Protoporphyria (EPP) Melanotan-1 Melanotan-1 (afamelanotide/Scenesse) is the only EMA-approved treatment for EPP, with Phase 3 RCT data showing increased pain-free sun exposure and improved quality of life Vitiligo Adjunct Therapy Melanotan-1 Small RCT data shows faster and deeper repigmentation when afamelanotide implants are combined with NB-UVB phototherapy compared to phototherapy alone Photoprotection Research Melanotan-1 Melanotan-1 enhances eumelanin production and DNA repair mechanisms with a favorable safety profile established across multiple clinical trials Melanocortin Receptor Pharmacology Melanotan-2 Melanotan-2 nonselective receptor profile makes it a useful research tool for studying MC1R through MC5R signaling pathways Sexual Dysfunction Research Melanotan-2 Melanotan-2 MC4R activation produces erectogenic effects
US$ 21.39
US$ 24.03
US$ 23.98
US$ 20.45
US$ 21.27
US$ 22.88
US$ 29.01
US$ 24.82
